Inner Mongolia Furui Medical Science Co., Ltd. (SHE:300049)

Market Cap	18.61B
Revenue (ttm)	1.47B
Net Income (ttm)	123.17M
Shares Out	264.98M
EPS (ttm)	0.47
PE Ratio	149.52
Forward PE	90.06
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,651,074
Average Volume	6,278,311
Open	65.66
Previous Close	65.60
Day's Range	64.48 - 70.50
52-Week Range	26.61 - 90.68
Beta	-0.46
RSI	52.74
Earnings Date	Apr 21, 2026

About SHE:300049

Inner Mongolia Furui Medical Science Co., Ltd. engages in the production and sale of pharmaceutical drugs in China and internationally. The company operates in two segments: pharmaceutical production and sales; and diagnostic equipment R&D, production and sales. The pharmaceutical production and sales segment produces and sells products, such as Fufang Biejiaruangan tablets and shell fat capsules. The diagnostic equipment R&D, production and sales segment develops, produces, and sells the FibroScan series of liver fibrosis diagnostic instrument...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1998
• Employees: 867
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300049

Financial Performance

In 2024, SHE:300049's revenue was 1.35 billion, an increase of 16.93% compared to the previous year's 1.15 billion. Earnings were 113.29 million, an increase of 11.54%.